Navigation Links
Circadian Commences First Phase 1 Clinical Trial of VEGF-C Antibody VGX-100 in Cancer Patients
Date:1/8/2012

progression during Avastin® treatment, implying that combination therapy with VGX-100 and Avastin® could significantly improve treatment outcomes in cancer patients.

Circadian's wholly owned subsidiary, Vegenics Pty Ltd, owns worldwide rights to an extensive intellectual property portfolio covering the angiogenesis and lymphangiogenesis targets VEGF-C, VEGF- D and the receptor protein VEGFR-3.  Vegenics has also been granted exclusive worldwide rights to intellectual property filed by Schepens Eye Research Institute covering the use of anti-lymphangiogenic molecules for the treatment of Dry Eye Disease.Company Enquiries:

Media Enquiries – International:  

 Robert Klupacs

Lauren Glaser Managing Director - Circadian

The Trout Group LLC Tel: +61 (0) 3 9826 0399 or

251 Post Street, Suite 412 robert.klupacs@circadian.com.au 

San Francisco, CA 94108  

Tel +1 215 740 8468  

lglaser@troutgroup.comAbout Circadian Technologies LimitedCircadian (ASX:CIR; OTCQX:CKDXY) is a biologics drug developer focusing on cancer and 'front of the eye' disease therapies.  It controls exclusive worldwide rights to a significant intellectual property portfolio around Vascular Endothelial Growth  Factor  (VEGF)-C and -D. The  applications for the  VEGF technology,  which functions in regulating blood and lymphatic vessel growth, are substantial  and broad. Circadian's internal product development programs are primarily focussed on  developing  VGX-100 (a human antibody against  VEGF-C) as a treatment for solid tumours, in particular glioblastoma and colorectal cancer, as well as for 'front of the eye' disease such as corneal neovascularisation and/or corneal allograft rejection.  Circadian has also licensed
'/>"/>

SOURCE Circadian Technologies Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Circadiance Launches Revolutionary New CPAP Tube
2. Circadian Receives FDA IND Approval to Begin Clinical Trials With VGX-100 for the Treatment of Cancer Patients With Solid Tumors
3. Circadian Files IND With FDA for VGX-100 for the Treatment of Cancer Patients With Solid Tumors
4. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
5. Ikaria® Commences Global Registration Trial for Bioabsorbable Cardiac Matrix
6. Coronado Biosciences Commences Public Trading on the OTC Bulletin Board
7. Hotspur Technologies Commences US Launch at Veith/AIM Conference in New York City
8. CryoLife Commences Tender Offer for All Outstanding Shares of Cardiogenesis Corporation
9. Unilife Commences Initial Production of Unifill Prefilled Syringe
10. Quest Diagnostics Commences Tender Offer for Acquisition of Celera
11. Milestone Scientific Inc. Commences Trading on the OTC Pink
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , July 2, 2015 According to ... Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation), ... Global Forecast to 2020", published by MarketsandMarkets, the global Neuromodulation ... projected to reach $6.20 Billion by 2020, at a CAGR ... 8 4 market data T ...
(Date:7/2/2015)... , June 25, 2015 Research and ... Diagnostics Market by Technology, Imaging and by Application - Forecast to ... diagnostics market is expected to reach $13.1 Billion in 2020 from ... 12.9%. The market is dominated by North ... Asia , and Rest of the World (RoW). The ...
(Date:7/2/2015)...  The Green Exchange, Inc., the developer,s of "Loud ... mobile app that connects cannabis growers directly to patients ... today that their service provides the fastest delivery on ... than half a dozen other delivery apps that have ... unique in that it connects growers directly with ...
Breaking Medicine Technology:Neuromodulation Market Worth $6.20 Billion by 2020 2Neuromodulation Market Worth $6.20 Billion by 2020 3Neuromodulation Market Worth $6.20 Billion by 2020 4Global Cancer Diagnostics Market Report 2015 - Technology, Imaging and by Applications Forecasts to 2020 for the $13 Billion Industry 2New Cannabis Delivery App Gets Product to Patient in Under 7 Minutes 2
(Date:7/3/2015)... ... 03, 2015 , ... Smoothies are all the rage right now and all ... quality ingredients. Aurora Natural is proud to introduce a new line of all natural ... antioxidants, vitamins and minerals! , Aurora is offering a variety of blends and stand-alone ...
(Date:7/3/2015)... ... July 03, 2015 , ... Yisrayl Hawkins, Pastor and ... this week that he says will reveal biblical truth and expose popular lies regarding ... Your Bible Say Don’t Have Sex”, immediately goes into the core of the subject ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased ... now the 19th sweetFrog store located in the Lone Star State. The premium frozen ... companies in 2014. , The store, which opened July 1 at Duke’s Travel Plaza, ...
(Date:7/2/2015)... Vancouver, BC (PRWEB) , ... July 02, 2015 , ... With summer in full swing, ... , Canada is one of the top spots for fishing in the world, and it’s ... and rivers of Ontario, Canada has great fish. , Recreational fishing is a huge ...
(Date:7/2/2015)... ... 2015 , ... Global leader and compression innovator, SIGVARIS North America, ... , For style that’s quick on its feet, men will love this fun new ... men everywhere because a simple change in socks can dramatically help improve overall leg ...
Breaking Medicine News(10 mins):Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3
... study finds pricetag hits $42 million a year , THURSDAY, July ... of 20 cost at least $42 million a year, a new ... and four per 100,000 young people annually, said Dr. Warren Lo, ... Stroke , but there is growing concern about the cost ...
... and Blue Shield of Illinois (BCBSIL) announced today ... Springfield-based initiatives designed to teach children how to ... them. Rather than funding individual organizations, the ... underserved neighborhoods that foster collaboration among multiple organizations ...
... evidence yet that fewer daily calories boost lifespan , THURSDAY, ... that a lower-calorie diet slowed the aging process in monkeys ... do the same for humans. , "The big question in ... to humans slow aging?," said Richard Weindruch, senior author of ...
... , SHENZHEN, China, July 9 /PRNewswire-FirstCall/ - Hard ... announced today and as previously released on June ... of reasserting its ownership rights to certain intellectual ... management of HTDS. 100% of the ownership rights ...
... LOS ANGELES (July 8, 2009) Carole Wagner Vallianos, ... Institute at Harbor-UCLA Medical Center (LA BioMed), will be inaugurated ... Annual Meeting in Chicago on July 30. Founded in ... organization of judges, lawyers and other members of the public ...
... University of Phoenix today announced the launch of ... degree in Nursing (Ph.D.) and an Educational Specialist (Ed.S.) degree. ... Ed.S. program beginning later this month, and the Ph.D. Nursing ... be offered through the University,s School of Advanced Studies (SAS). ...
Cached Medicine News:Health News:Stroke in Children Rare But Costly 2Health News:Stroke in Children Rare But Costly 3Health News:Blue Cross and Blue Shield of Illinois Awards $1.4 Million to 14 Community Initiatives in Chicago and Downstate 2Health News:Lighter Meals May Bring Longer Life 2Health News:Lighter Meals May Bring Longer Life 3Health News:Hard To Treat Diseases (HTDS.PK) Reasserting Multi Million Dollar IP Ownership Rights 2Health News:Hard To Treat Diseases (HTDS.PK) Reasserting Multi Million Dollar IP Ownership Rights 3Health News:LA BioMed President and CEO will be named president of the American Judicature Society 2Health News:University of Phoenix Expands Advanced Degree Programs; Adds Ph.D. in Nursing and Educational Specialist Degrees 2Health News:University of Phoenix Expands Advanced Degree Programs; Adds Ph.D. in Nursing and Educational Specialist Degrees 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: